This is very promising data. Actually, there are a lot of groups looking at the potential using of OCT. I didn’t mention before, but we also run in this group of patients OCT studies and there is evidence of retinal nerve fiber layer thinning even in the early stage of the disease. But also there are also a lot of promising results about angiography or CT angiography, so looking at the vessels...
This is very promising data. Actually, there are a lot of groups looking at the potential using of OCT. I didn’t mention before, but we also run in this group of patients OCT studies and there is evidence of retinal nerve fiber layer thinning even in the early stage of the disease. But also there are also a lot of promising results about angiography or CT angiography, so looking at the vessels. And also, there is a group looking also at the possibility of evaluating the deposition of amyloid in vivo, using for example, curcumin. So, there are a lot of areas of development and the possible use of biomarker also for clinical studies or therapeutic interventions.
